CRL NYSE Week ended 31 Jul 2026

Weekly Investor Report

Charles River Laboratories · Healthcare · Diagnostics & Research

Latest close 232.5 USD
2.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 23.1% above the Trend Line and sits at 89.6% of its 52-week range. The latest completed week returned 2.6%, after a 0.8% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 58/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 4d.

Setup score 61 out of 100
Latest Close 232.5 USD 31 Jul 2026
1W Return 2.6% latest completed week
4W Return 0.8% short-term follow-through
12W Return 30.9% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 23.1% above the Trend Line and sits at 89.6% of its 52-week range. The latest completed week returned 2.6%, after a 0.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6112-week average 0.31

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.61Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.8% over four weeks, 30.9% over 12 weeks, and 39.3% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W2.6%
4W0.8%
12W30.9%
26W10.5%
52W39.3%
Active trend streak3 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.17Latest activity-pressure read.
Pressure change22.2%Four-week change in activity pressure.
Leadership17.48Latest relative-leadership reading.
RS change-4.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength18/100Blend of value, momentum, and quality. Underlying universe rank 83; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality19/100Profitability and accounting quality. Underlying universe rank 82; rank 1 is best.
Momentum74/100Medium-term price momentum. Underlying universe rank 27; rank 1 is best.
Growth25/100Revenue and earnings growth. Underlying universe rank 76; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2.7x
Market value relative to trailing revenue.
EV / EBITDA
47.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
31.9%
Gross profit retained from each unit of revenue.
Operating margin
-1.5%
Operating profit retained from revenue.
Free-cash-flow margin
20.4%
Free cash flow generated from revenue.
Return on invested capital
-0.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
0.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-16.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
2.0%
Net share repurchases relative to market value.
Shareholder yield
2.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
9.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CRL shows volatility options pressure with a 58/100 conviction score, put-call volume ratio of 53.50, expected move of 12.6%, and Sharemaestro trend signal active.

Conviction58/100
Expected move12.6%
Put/call volume53.50
Pressure-89
Speculation41
Volatility86
Trend agreement13
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 53 relevant articles.

20 positive · 24 neutral · 9 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move12.6%Nearest-chain priced movement where available.
52-week drawdown-4.2%Distance below the 52-week high.
13-week volatility7.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+16.6%Week of 26 Jun.
Worst week-15.1%Week of 15 May.
Latest week+2.6%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains7
Flat weeks0
Modest losses5
Sharp losses5
Recent vol7.5%13-week weekly-return volatility.
Base vol7.0%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew5.5% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026232.5 USD2.6%188.9 USD190.0 USD1.1717.484.5MOn
24 Jul 2026226.6 USD1.0%187.9 USD189.9 USD1.1916.084.0MOn
17 Jul 2026224.3 USD-3.9%187.1 USD189.8 USD1.3614.484.4MOn
10 Jul 2026233.4 USD1.2%186.2 USD189.6 USD1.1717.713.7MOff
3 Jul 2026230.7 USD6.9%184.9 USD189.5 USD0.9618.374.1MOff
26 Jun 2026215.8 USD16.6%183.3 USD189.3 USD0.6413.575.2MOff
19 Jun 2026185.0 USD-1.3%182.1 USD189.3 USD0.34-4.593.5MOff
12 Jun 2026187.5 USD3.4%181.5 USD189.4 USD0.20-2.423.4MOff
5 Jun 2026181.3 USD0.3%180.8 USD189.6 USD-0.09-5.093.5MOff
29 May 2026180.7 USD12.7%180.4 USD189.7 USD-0.17-7.784.6MOff
22 May 2026160.3 USD6.3%180.4 USD189.8 USD-0.53-16.975.0MOff
15 May 2026150.8 USD-15.1%181.6 USD190.0 USD-0.71-21.324.4MOff
8 May 2026177.6 USD7.1%182.5 USD190.3 USD-0.66-7.405.3MOff
1 May 2026165.8 USD-2.4%182.2 USD190.4 USD-0.79-11.593.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.